Precision Business Insights has published a report on the global long-acting drug delivery market, estimating its value at USD 1.21 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 12.2% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/long-acting-drug-delivery-market
The Long-Acting Drug Delivery Market is concerned with the research and marketing of pharmaceutical formulations that release therapeutic ingredients for lengthy periods of time—ranging from weeks to months—following a single dosage. These systems include injectables, implants, transdermal patches, and oral formulations that keep medication levels stable throughout the body, increasing patient compliance and decreasing dose frequency.
Drivers:
- Rising prevalence of diabetes, cancer, and cardiovascular conditions
- Growth in protein-based and gene therapies requiring sustained delivery
The global long-acting drug delivery market segmentation:
1) By Type: First Generation, Second Generation
2) By Route of administration: Parenteral, Injectables, Oral, Others
3) By Application: Ophthalmic Disorders, Oncological Disorders, Neurological Disorders, Infectious Diseases
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=514185
Regional Overview:
The report also examines the current concerns and their Future Effects on the long-acting drug delivery market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the long-acting drug delivery market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Eli Lilly and Company, Janssen Pharmaceutical, Cipla, GSK Plc, Alnylam Pharmaceuticals, Heron Therapeutics, Nanexa AB, Amorphex Therapeutics, AstraZeneca, Bostal Drug Delivery Co., Ltd.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
